FDA Submission Expected This Summer - Invest Before It Happens
This company is making heart disease easier to detect with AI. Their tech has officially been designated a "Breakthrough" by the FDA. You now have an opportunity to get in at a potential inflection point.
Shares Stats
| Shares Outstanding | 93,740,000 |
| Shares Float | 88,380,000 |
| Shares Short | 8,800,000 |
| Insider Holdings | 320% |
| Institution Holdings | 99.43% |
About Ultragenyx Pharmaceutical Inc
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Latin America, Europe, the Middle East, Africa, and the Asia-Pacific. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast growth factor 23 for the treatment of X-linked hypophosphatemia, as well as tumor-induced osteomalacia; Mepsevii, an enzyme replacement therapy for the treatment of children and adults with Mucopolysaccharidosis VII; Dojolvi for the treatment of long-chain fatty acid oxidation disorders; and Evkeeza (evinacumab) for the treatment of homozygous familial hypercholesterolemia. The company's products candidates that are in Phase 3 clinical trials include UX143, a human monoclonal antibody for the treatment of osteogenesis imperfecta; UX111, an AAV9 gene therapy product candidate for the treatment of patients with Sanfilippo syndrome type A, or MPS IIIA, a rare lysosomal storage disease; DTX401, an adeno-associated virus 8 (AAV8) gene therapy clinical candidate for the treatment of patients with glycogen storage disease type Ia; DTX301, an AAV8 gene therapy for the treatment of patients with ornithine transcarbamylase; and GTX-102, an antisense oligonucleotide for the treatment of Angelman syndrome. It also develops UX701 that is in Phase 2 clinical trial for the treatment of Wilson disease; and UX053 for the treatment of glycogen storage disease type III. Ultragenyx Pharmaceutical Inc. has collaboration and license agreement with Kyowa Kirin Co., Ltd.; Saint Louis University; Baylor Research Institute; REGENXBIO Inc.; GeneTx; Mereo; University of Pennsylvania; Solid Biosciences Inc.; Regeneron; Abeona; and Arcturus Therapeutics Holdings Inc. The company was incorporated in 2010 and is headquartered in Novato, California.
General
| Name | Ultragenyx Pharmaceutical Inc |
| Ticker | RARE |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Currency | USD |
| Country | USA |
| Fiscal Year End | December |
| Full Time Employees | 1,294 |
Highlights
| Analyst Target | 84.60 |
| Market Cap | 2,582,900,000 |
| PEG Ratio | -0.24 |
| EBITDA | -477,876,992 |
Financials
| Curr Year EPS Estimate | -5.32 |
| Next Quarter EPS Estimate | -1.39 |
| Profit Margin | -93.04% |
| Operating Margin | -86.94 |
| Return on Assets | -0.25 |
| Return on Equity | -3.77 |
| Revenue | 590.7M |
| Earnings Per Share | -5.83 |
| Revenue Per Share | 6.32 |
| Gross Profit | -182,318,000 |
| Quarterly Revenue Growth | 0.28 |
Valuation
| Price/Sales (Trailing 12 Mt.) | 4.37 |
| Price/Book (Most Recent Quarter) | 17.79 |
Earnings
Trump Says 5 Jets Downed During India-Pakistan Conflict: '...Shot Out Of The Air'
President Donald Trump during a dinner with Republican lawmakers stated, that up to 5 jets were shot down during the India-Pakistan conflict.
Jim Cramer Recommends This 'Really, Really Good' Energy Stock
Cramer also looks at Shutterstock and Getty. One of these companies "doesn't really have the growth" that he'd like to see.
Tap Into the $65B 'Shroom Boom' - Ad
People are rapidly discovering how mushrooms can enhance brain function, gut health, immunity, and more. The only thing holding them back? A simple way to grow them. Hypha Labs built a compact countertop device to solve exactly that.
Rigetti Computing, Netflix, Johnson & Johnson, United Airlines And ASML: Why These 5 Stocks Are On Investors' Radars Today
U.S. stocks moved higher today, with the Dow Jones gaining more than 200 points, or 0.5%, to close at 44,254.78.
Draganfly Stock Is Moving Higher Wednesday: What's Going On?
Dragonfly shares are trading higher Wednesday after the company announced its Cammander3 XL UAV has been selected by the Department of Defense for advanced operation initiatives.
Palantir Makes a Move - Now Look At the Chart - Ad
One under-the-radar company just partnered with Palantir to take autonomous security to the next level.
Mark Cuban Praised His 'Hustling' Son, But Told Kids: 'Figure Out Who You Are, You Don't Need To Follow In My Footsteps'
Jake Cuban embarked on an entrepreneurial journey reminiscent of his father's early business ventures by starting a side hustle selling candy at his school.
Drone attacks on oil fields in Iraq's Kurdish region shut down another facility
BAGHDAD (AP) — Drones targeted Wednesday, the latest in a series of attacks in recent days that have put several oil facilities out of commission.
Investing Legend Hints the End May Be Near for These 3 Iconic Stocks - Ad
Futurist Eric Fry say Amazon, Tesla and Nvidia are all on the verge of major disruption. To help protect anyone with money invested in them, he's sharing three exciting stocks to replace them with. He gives away the names and tickers completely free in his brand-new "Sell This, Buy That" broadcast.
ASML Stock Plunges Nearly 8% In Wednesday Pre-Market: What's Going On?
Shares of Dutch semiconductor firm, ASML Holding NV (NASDAQ: ASML), has declined 7.46% during Wednesday pre-market trading, after the company expressed concerns over its 2026 growth prospects.
Elon Musk Once Revealed How He Comes Up With 'Crazy Ideas' — And Gets Them Off The Ground Even When Funding Is Scarce
Elon Musk once explained that he turns ambitious ideas into reality by starting with low-cost software ventures, using first principles thinking, and combining insights across industries—even without major funding.
Is Elon's Empire Crumbling? - Ad
Jeff Brown - the legend who called Tesla and Nvidia early - says Elon is about to launch a $25T AI revolution. This isn't another chatbot. It's real-world AI that could 14X the impact of ChatGPT. But after October 23rd, it may be too late.
Elon Musk Changed His Number, Became Unreachable After Trump Feud, Reveals Speaker Mike Johnson: 'I Sent Him A Long Text Message, And Then...'
Tesla Inc. (NASDAQ: TSLA) CEO Elon Musk has reportedly changed his phone number following a fued with President Donald Trump and disagreement with Speaker Mike Johnson over the Republican's tax-and-spending bill.
Inside the high-stakes battle to win a New York City casino license
NEW YORK (AP) — A Caesars Palace casino in the heart of Times Square. A sprawling gambling hall along Coney Island’s iconic boardwalk. A Hard Rock casino complex next to the home stadium of baseball’s New York Mets.
Back the Biotech Company Unlocking Mushroom Health Benefits for All - Ad
Functional mushrooms can boost mental, gut, and immune health-but people can't grow them at home. One company is making it easy with a patent-pending kitchen device. Think Nespresso, but for mushrooms. The functional mushroom market is projected to nearly double by 2030.
Trump Diagnosed With Chronic Venous Insufficiency, A Common Circulatory Condition In Over-70s, White House Says He's 'In Excellent Health'
The White House revealed President Trump is diagnosed with chronic health condition.
Oklo Stock Hit A New 52-Week High Today: What's Driving The Action?
Shares of advanced nuclear technology company Oklo are trading higher Thursday. The company announced a strategic alliance with Liberty Energy on Wednesday.
If You Missed Tesla, Here's Your "Second Chance"... - Ad
If you missed your shot at turning $1,000 into more than $18,000 when I recommended Tesla, you'll want to pay close attention. I'm 100% convinced Elon's "Agenda X" could make early investors rich. But you need to hurry, because Elon and Visa are moments away from launching.
Japanese leader Ishiba vows to remain despite speculation, says he will focus on new US trade deal
TOKYO (AP) — Prime Minister on Wednesday vowed to remain in power to oversee the implementation of a , despite media speculation and growing calls for him to resign after a .
OpenAI's Sam Altman warns of AI voice fraud crisis in banking
WASHINGTON (AP) — OpenAI CEO Sam Altman warned the financial industry of a “significant impending fraud crisis” because of the ability of artificial intelligence tools to impersonate a person's voice to bypass security checks and move money.
Back This Medical AI Tech - Ad
You don't often find healthcare tech company valued at $4M. HeartSciences is an exception. With $75M invested, including R&D, clinical trials, and product development, their patented AI software is approaching FDA submission, a potential major inflection point.
ASML Rises 1.1% After Key Trading Signal
A significant trading signal occurred for ASML Holding stock as it demonstrated a power inflow at $817.45, after which ASML rose up to 1.1%.
Retirees, here’s how to tweak the 4% rule to protect your nest egg
New retirees might enter a different environment than their predecessors—the economy or market might have changed slightly or dramatically.
How to Hack a $1.3T Market - Ad
Forget concrete. The new foundation for real estate success is digital, and Pacaso leads the way. Their tech unlocks a $1.3T real estate market. They've already earned $110M+ in gross profits in their operating history and reserved the Nasdaq ticker PCSO.
Trump-Xi Meeting On Horizon As US-China Hold Marathon 5-Hour Trade Talks In Stockholm
Officials from US and China met in Stockholm to extend trade truce, resolve economic disputes. Talks continue, Trump wants China to open economy.
Leaders of the UK and Germany to sign a treaty on defense, trade and migration
LONDON (AP) — and are set to sign a treaty on Thursday pledging to tighten defense ties and step up law-enforcement cooperation against gangs that smuggle migrants .
Palantir's AI Is Going Physical - Ad
The next wave of security AI is happening now. Palantir just joined forces with a company already doing the work.
Cathie Wood Pounces On Tesla Dip: Ark Snaps Up $43.7 Million In EV Stock While Ditching Crypto Shares Amid Bitcoin Frenzy
On Thursday, Cathie Wood-led Ark Invest made significant trades, prominently featuring the purchase of Tesla Inc. (NASDAQ:TSLA) shares across multiple ETFs.
$500 Billion Stumble: SoftBank–OpenAI's Massive AI Vision Faces Setbacks
Stargate has run into major delays and now plans to build a much smaller facility by the end of 2025.
FDA Submission Expected This Summer - Invest Before It Happens - Ad
This company is making heart disease easier to detect with AI. Their tech has officially been designated a "Breakthrough" by the FDA. You now have an opportunity to get in at a potential inflection point.
Martin Luther King Jr. FBI Records Released By Trump Administration: Al Sharpton Says, 'Desperate Attempt' To Distract People From Epstein Firestorm
Trump administration released over 240,000 pages of FBI surveillance records on Martin Luther King Jr., sparking controversy among his family and civil rights organizations.
Lin-Manuel Miranda will turn 'Hamilton' 10th anniversary into a fundraiser for immigration services
plans to use the Broadway performance of his award-winning cultural phenomenon as a fundraiser for a coalition of nonprofits providing immigration services.
Tap Into the $65B 'Shroom Boom' - Ad
People are rapidly discovering how mushrooms can enhance brain function, gut health, immunity, and more. The only thing holding them back? A simple way to grow them. Hypha Labs built a compact countertop device to solve exactly that.
Trump administration imposes limits on Mexican flights and threatens Delta alliance in trade dispute
The Trump administration imposed new restrictions Saturday on flights from Mexico and threatened to end a longstanding partnership between Delta Air Lines and Aeromexico in response to limits the Mexican government placed on passenger and cargo flights into Mexico City several years ago.
Bitcoin Consolidates Amid Trump's Tariff Moves; Ethereum, Dogecoin Fall: Analyst Foresees 'Violent' ETH Rally Once It Breaks This Level
Leading cryptocurrencies diverged from stocks on Wednesday as investors parsed tariff-related developments ahead of the Aug. 1 deadline.
Palantir Makes a Move - Now Look At the Chart - Ad
One under-the-radar company just partnered with Palantir to take autonomous security to the next level.
Elon Musk Returns To Intense Work Schedule: 'Back To Working 7 Days a Week and Sleeping in the Office'
Elon Musk has announced his return to a grueling work schedule, indicating a shift back to "wartime CEO" mode.
Microsoft Raids Google DeepMind To Supercharge AI Copilot, Even As Redmond Cuts 9,000 Jobs Elsewhere: Report
Microsoft has hired around two dozen engineers from Google DeepMind to strengthen its AI team and accelerate Copilot development, intensifying the talent war among tech giants.
Investing Legend Hints the End May Be Near for These 3 Iconic Stocks - Ad
Futurist Eric Fry say Amazon, Tesla and Nvidia are all on the verge of major disruption. To help protect anyone with money invested in them, he's sharing three exciting stocks to replace them with. He gives away the names and tickers completely free in his brand-new "Sell This, Buy That" broadcast.
Trump Says $550 Billion Trade Deal With Japan Reached That Will Create 'Hundreds Of Thousands' Of Jobs: 'There Has Never Been Anything Like It' (CORRECTED)
President Trump declared a $550 billion trade deal with Japan, focusing on job creation and market access for U.S. products. Tariffs also agreed upon.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.